SCHEMBL3543497

SCHEMBL3543497

c1ccc(CC2C3CC4CC(C3)CC2C4)cc1

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.47
EPHX2 P34913 5/20 0.47
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CXCR3 P49682 2/20 0.41
GBA1 P04062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3672132 0.79 POLB (0.46) HSD11B1CXCR3
SCHEMBL17082719 0.79 GBA1 (0.43) HSD11B1GBA1
SCHEMBL251038 0.77 HSD11B1 (0.36) HSD11B1EPHX2CHRM2CHRM4CHRM5
SCHEMBL3987029 0.76 HSD11B1 (0.41) HSD11B1EPHX2CHRM2CHRM4CHRM5
SCHEMBL17082729 0.76 HSD11B1 (0.55) HSD11B1EPHX2
SCHEMBL23023204 0.75 CXCR3 (0.71) EPHX2CXCR3
SCHEMBL9371881 0.75 GBA1 (0.48) GBA1
SCHEMBL12875947 0.74 SMN1; SMN2 (0.67) HSD11B1EPHX2CXCR3
SCHEMBL13397148 0.74 SMN1; SMN2 (0.67) HSD11B1EPHX2CXCR3
SCHEMBL3359767 0.74 SMN1; SMN2 (0.67) HSD11B1EPHX2CXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11502329-B2 Pre-cell formation electrodes and lithium ion batteries GOTION, INC. (US) 2022-11-15 US claimed
CN-112480305-A Adamantyl phenyl sulfonate based polymeric flame retardant, preparation method and application 广东知塑新材料有限公司 2021-03-12 CN claimed
US-20200365936-A1 PRE-CELL FORMATION ELECTRODES AND LITHIUM ION BATTERIES Gotion Inc. (US) 2020-11-19 US claimed
US-10826111-B2 Pre-cell formation electrodes and lithium ion batteries GOTION, INC. (US) 2020-11-03 US claimed
US-20190326625-A1 Pre-Cell Formation Electrodes And Lithium Ion Batteries GOTION, INC. 2019-10-24 US claimed
US-12334502-B2 Electrolytes for lithium-containing battery cells APPLE INC. (US) 2025-06-17 US disclosed
US-20240136585-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS APPLE INC. (US) 2024-04-25 US disclosed
US-11881558-B2 Electrolytes for lithium-containing battery cells APPLE INC. (US) 2024-01-23 US disclosed
CN-116914244-A High concentration lithium ion electrolyte for battery cells 苹果公司 2023-10-20 CN disclosed
US-20230335785-A1 HIGH-CONCENTRATION LITHIUM-ION ELECTROLYTES FOR BATTERY CELLS APPLE INC. (US) 2023-10-19 US disclosed
US-11502329-B2 Pre-cell formation electrodes and lithium ion batteries GOTION, INC. (US) 2022-11-15 US disclosed
US-20210218061-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS APPLE INC. (US) 2021-07-15 US disclosed
US-20200365936-A1 PRE-CELL FORMATION ELECTRODES AND LITHIUM ION BATTERIES Gotion Inc. (US) 2020-11-19 US disclosed
US-10826111-B2 Pre-cell formation electrodes and lithium ion batteries GOTION, INC. (US) 2020-11-03 US disclosed
US-20190326625-A1 Pre-Cell Formation Electrodes And Lithium Ion Batteries GOTION, INC. 2019-10-24 US disclosed
US-7855241-B2 Method of improving abrasion resistance of plastic article using nanoparticles and article produced thereby SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-12-21 US disclosed
EP-1945695-A2 METHOD OF IMPROVING ABRASION RESISTANCE OF PLASTIC ARTICLE USING NANOPARTICLES AND ARTICLE PRODUCED THEREBY General Electric Company (US) 2008-07-23 EP disclosed
WO-2007047294-A2 METHOD OF IMPROVING ABRASION RESISTANCE OF PLASTIC ARTICLE USING NANOPARTICLES AND ARTICLE PRODUCED THEREBY GENERAL ELECTRIC COMPANY (US) 2007-04-26 WO disclosed
US-20070088095-A1 Method of improving abrasion resistance of plastic article using nanoparticles and article produced thereby GENERAL ELECTRIC COMPANY (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210218061-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS CEL, CA3, SLC9B2 HSD11B1 509/4885EPHX2 3424/4885CHRM2 3842/4885
US-20240136585-A1 ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS CEL, CA3, SLC9B2 HSD11B1 509/4885EPHX2 3424/4885CHRM2 3842/4885
US-11881558-B2 Electrolytes for lithium-containing battery cells CEL, CA3, SLC9B2 HSD11B1 509/4885EPHX2 3424/4885CHRM2 3842/4885
US-12334502-B2 Electrolytes for lithium-containing battery cells CEL, CA3, SLC9B2 HSD11B1 509/4885EPHX2 3424/4885CHRM2 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.